Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
weakness
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
The patient is a ___ woman with a history of seizure 
disorder and Coffin ___ X link syndrome p/w weakness after 
urinary tract infection. Pt was brought in by ambulance after 
her at home caretaker found that she was having trouble 
transferring. She was apparently on the floor for several hours 
yesterday. She went to urgent care and dx with UTI. She denies 
f/c/cp/sob/n/v. She states she has increased urinary frequency, 
no dysuria or hematuria. She denies abdominal pain. She came in 
because PCP was ___. She denies HA, hemoptysis, ___ 
swelling. 
In the ED, initial VS were 
98.4  100  146/92  18  99% RA 
Labs showed no leukocytosis and unremarkable UA. Lactate wnl. 
Imaging showed no acute cardiopulmonary process (reviewed in 
OMR).
Received Ceftraixone
Transfer VS were 99.3, 104, 139/97, 16, 95% RA 

Decision was made to admit to medicine for further management.  

On arrival to the floor, patient reports she was feeling very 
weak today from her urinary tract infection and she was unable 
to transfer from her bed to her wheelchair, which is atypical 
for her. She is unable to walk due to valgus deformity of her 
legs.  She did not report any dizziness, lightheadedness or 
falls. She denies dysuria or suprapubic pain. She has urinary 
incontinence at baseline. 

 
Past Medical History:
- Typical Coffin ___ X link syndrome (the mutation is on 
RPS6KA3 gene ribosomal protein S6 kinase A3). 
- Grand mal seizure disorder
 
Social History:
___
Family History:
Mother had colon cancer and leukemia
 
Physical Exam:
ADMISSION EXAM:
================
VS: 98.9 146 / 88 99 18 98 RA  
GENERAL: NAD, sitting comfortably in bed
HEENT: AT/NC, enlarged lips and tongue 
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: valgus deformity of lower extremities. Enlarged 
fingers in bilateral hands.
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

DISCHARGE EXAM:
================
VITALS: 97.8 133 / 89 97 18 96 Ra
GENERAL: NAD, sitting comfortably in bed
HEENT: AT/NC, enlarged lips and tongue
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly
EXTREMITIES: valgus deformity of lower extremities. Enlarged 
fingers in bilateral hands.
PULSES: 2+ DP pulses bilaterally
NEURO: CN II-XII intact, strength ___ in bilateral upper and 
lower extremities, sensation to light touch intact bilaterally.
SKIN: warm and well perfused, papular lesion with 
hyperpigmentation 2cm in diameter located on top of back
 
Pertinent Results:
ADMISSION LABS:
===============
___ 04:15PM BLOOD WBC-7.1 RBC-3.78* Hgb-11.5 Hct-37.0 
MCV-98 MCH-30.4 MCHC-31.1* RDW-12.9 RDWSD-46.7* Plt ___
___ 04:15PM BLOOD Neuts-63.1 ___ Monos-11.6 Eos-1.3 
Baso-0.4 Im ___ AbsNeut-4.48 AbsLymp-1.65 AbsMono-0.82* 
AbsEos-0.09 AbsBaso-0.03
___ 04:15PM BLOOD Plt ___
___ 04:15PM BLOOD Glucose-96 UreaN-12 Creat-0.5 Na-139 
K-7.9* Cl-102 HCO3-28 AnGap-17
___ 04:15PM BLOOD ALT-<5 AST-66* CK(CPK)-252* AlkPhos-191* 
TotBili-<0.2
___ 04:15PM BLOOD Albumin-3.8
___ 04:15PM BLOOD K-4.2

DISCHARGE LABS:
================

MICRO:
======
___ 7:10 pm URINE
URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 
      ESCHERICHIA COLI.    >100,000 CFU/mL.  PRESUMPTIVE 
IDENTIFICATION. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
         PREDOMINATING ORGANISM INTERPRET RESULTS WITH CAUTION. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--    16 I
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

___ 5:15 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    < 10,000 CFU/mL. 
___ BLOOD CULTURE X2 WITH NO GROWTH TO DATE

IMAGING:
========
___ CXR:
AP upright and lateral views of the chest provided.  Low lung 
volumes.  The patient's chin partially obscures the lung apices. 
 Allowing for these 
limitations, and there is no focal consolidation, effusion or 
pneumothorax.  Cardiomediastinal silhouette appears within 
normal limits.  Periarticular calcifications at the shoulders 
may reflect CPPD arthropathy.  Bony structures appear slightly 
demineralized.  No acute osseous abnormality. 

 
Brief Hospital Course:
___ woman with a history of seizure disorder and ___ 
___ X link syndrome p/w weakness after recent diagnosis of 
urinary tract infection.

#Weakness: 
She developed fatigue and weakness prior to admission with more 
difficulty than usual when transferring from her bed to her 
wheelchair. Likely secondary to urinary tract infection and 
underlying ___ ___ X link syndrome. Labs were unrevealing 
with normal CBC, Chem7. EKG without evidence of ischemia. She 
worked with ___ who recommended rehab, her stay in rehab not to 
exceed 30 days. 

#Urinary tract infection:
She went to urgent care on ___ and dx with UTI, found to 
have pansensitive E. coli on UCx. Patient received ceftriaxone 
x2 but was transitioned to po cefpodoxime for planned 7 day 
course (end ___.

#Seizure disorder: She has h/o generalized seizures though none 
for many years and is on Dilantin and Keppra which was continued 
during hospitalization.  

TRANSITIONAL ISSUES
===================
- Patient discharged on cefpodoxime with plan to complete a ___nding ___
- Please monitor hyperpigmented lesion on patient's back.
- Patient will need assistance with arranging more supportive 
housing environment on discharge from rehab as she feels unable 
to care for herself anymore. 

**Patient's stay in rehab facility not to exceed 30 days. 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. LevETIRAcetam 500 mg PO BID 
2. Phenytoin Sodium Extended 300 mg PO DAILY 
3. Vitamin D ___ UNIT PO DAILY 
4. Multivitamins 1 TAB PO DAILY 
5. Cefpodoxime Proxetil 100 mg PO Q12H urinary tract infection 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 100 mg PO Q12H urinary tract infection 
RX *cefpodoxime 100 mg 1 tablet(s) by mouth every twelve (12) 
hours Disp #*9 Tablet Refills:*0 
2.  LevETIRAcetam 500 mg PO BID  
3.  Multivitamins 1 TAB PO DAILY  
4.  Phenytoin Sodium Extended 300 mg PO DAILY  
5.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
urinary tract infection

Secondary:
seizure disorder
___ X link syndrome 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

You were seen at ___ due to weakness. You were found on the 
floor and you were unable to transfer between bed and your 
wheelchair. This is a new change for you and was concerning. We 
think your weakness may have been related to a urinary tract 
infection, so we gave you antibiotics and fluids to help. You 
were seen by a physical therapist who recommended that you go to 
a rehabilitation facility to help improve your strength. 

Please continue to take your antibiotics for 7 days, ending 
___. This medication is called cefpodoxime.

Please follow up at the appointments we have arranged.

It was a pleasure taking care of you at ___.

Sincerely, 
Your care team
 
Followup Instructions:
___